Integer Holdings Corporation (ITGR)

Market Cap	2.86B -26.7%
Revenue (ttm)	1.86B +6.3%
Net Income	141.80M +84.4%
EPS	3.97 +82.2%
Shares Out	34.07M
PE Ratio	21.17
Forward PE	13.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,035,640
Open	87.85
Previous Close	88.51
Day's Range	83.19 - 90.00
52-Week Range	62.00 - 127.06
Beta	0.66
Analysts	Buy
Price Target	92.86 (+10.51%)
Earnings Date	Apr 30, 2026

About ITGR

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, impl...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 29, 2000
• Employees: 11,000
• Stock Exchange: NYSE
• Ticker Symbol: ITGR
• Website: https://www.integer.net

Financial Performance

In 2025, Integer Holdings's revenue was $1.85 billion, an increase of 7.98% compared to the previous year's $1.72 billion. Earnings were $102.81 million, a decrease of -14.25%.

Analyst Summary

According to 7 analysts, the average rating for ITGR stock is "Buy." The 12-month stock price target is $92.86, which is an increase of 10.51% from the latest price.

Price Target

$92.86

(10.51% upside)

Analyst Consensus: Buy